Congenital taurine deficiency in mice is associated with reduced sensitivity to nociceptive chemical stimulation

Neuroscience

Volumn 259, Issue , 2014, Pages 63-70

  Lotsch J ^a,b   Hummel, T ^c   Warskulat, U ^d   Coste, O ^a   Haussinger D ^d   Geisslinger, G ^a,b   Tegeder, I ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Applied Ecology Project Group Translational Medicine and Pharmacology (IME TMP) Fraunhofer Institute for Molecular Biology   (Germany)

^c UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Knock out model; Mice; Pain

Indexed keywords

CARBON DIOXIDE; TAURINE; TAURINE TRANSPORTER;

AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL TAURINE DEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; EVOKED RESPONSE; FORMALIN TEST; HOT PLATE TEST; KNOCKOUT MOUSE; LATENT PERIOD; LICKING; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; NOSE MUCOSA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SENSORY DYSFUNCTION; STIMULUS RESPONSE; WILD TYPE;

ANALYSIS OF VARIANCE FOR REPEATED MEASURES; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY; HSAN; KNOCK-OUT MODEL; MICE; NEGATIVE MUCOSA POTENTIAL; NMP; PAIN; RM-ANOVA;

ANALYSIS OF VARIANCE; ANIMALS; CARBON DIOXIDE; FORMALDEHYDE; HYPERALGESIA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOCICEPTION; PAIN MEASUREMENT; PAIN THRESHOLD; STIMULATION, CHEMICAL; TAURINE; TIME FACTORS;

EID: 84891136849     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.11.037     Document Type: Article

References (92)

1. Aerts L., Van Assche F.A. Taurine and taurine-deficiency in the perinatal period. J Perinat Med 2002, 30:281-286.
2. Aguirre G.D. Retinal degeneration associated with the feeding of dog foods to cats. J Am Vet Med Assoc 1978, 172:791-796.
3. 2 pulses applied to the nasal mucosa. Pain 1992, 49:53-60.
4. 2 pulses applied to the nasal mucosa. Neurosci Lett 1991, 123:208-211.
5. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
6. Black J.A., Hoeijmakers J.G.J., Faber C.G., Merkies I.S.J., Waxman S.G. NaV1.7: stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus. Mol Pain 2013, 9:39.
7. Bushnell M.C., Duncan G.H., Hofbauer R.K., Ha B., Chen J.I., Carrier B. Pain perception: is there a role for primary somatosensory cortex?. Proc Natl Acad Sci U S A 1999, 96:7705-7709.
8. Caggiula A.R., Epstein L.H., Perkins K.A., Saylor S. Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology (Berl) 1995, 122:301-306.
9. Camon E., Magrane M., Barrell D., Lee V., Dimmer E., Maslen J., Binns D., Harte N., Lopez R., Apweiler R. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with gene ontology. Nucleic Acids Res 2004, 32:D262-D266.
10. Cohen J. A power primer. Psych Bull 1992, 112:155-159.
11. Cui N., Zhang X., Tadepalli J.S., Yu L., Gai H., Petit J., Pamulapati R.T., Jin X., Jiang C. Involvement of TRP channels in the CO(2) chemosensitivity of locus coeruleus neurons. J Neurophysiol 2011, 105:2791-2801.
12. de Rienzo-Madero B., Coffeen U., Simon-Arceo K., Mercado F., Jaimes O., Magis-Weinberg L., Contreras B., Pellicer F. Taurine enhances antinociception PRODUCED by a COX-2 inhibitor in an inflammatory pain model. Inflammation 2013, 36:658-664.
13. Doty R.L., Brugger W.P.E., Jurs P.C., Orndorff M.A., Snyder P.J., Lowry L.D. Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 1978, 20:175-185.
14. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4:161-174.
15. Fechner G.T. Elemente der psychophysik 1860, Breitkopf and Härtel, Leipzig.
16. Foos T.M., Wu J.Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 2002, 27:21-26.
17. Frasnelli J., Schuster B., Hummel T. Interactions between olfaction and the trigeminal system: what can be learned from olfactory loss. Cereb Cortex 2007, 17:2268-2275.
18. French E.D., Vezzani A., Whetsell W.O., Schwarcz R. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol 1986, 203:349-362.
19. Gudziol V., Pietsch J., Witt M., Hummel T. Theophylline induces changes in the electro-olfactogram of the mouse. Eur Arch Otorhinolaryngol 2010, 267:239-243.
20. Han N.L., Haddrill J.L., Lynch J.W. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine. J Neurochem 2001, 79:636-647.
21. Hara K., Nakamura M., Haranishi Y., Terada T., Kataoka K., Sata T. Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain. Amino Acids 2012, 43:397-404.
22. Hawrylycz M.J., Lein E.S., Guillozet-Bongaarts A.L., Shen E.H., Ng L., Miller J.A., van de Lagemaat L.N., Smith K.A., Ebbert A., Riley Z.L., Abajian C., Beckmann C.F., Bernard A., Bertagnolli D., Boe A.F., Cartagena P.M., Chakravarty M.M., Chapin M., Chong J., Dalley R.A., Daly B.D., Dang C., Datta S., Dee N., Dolbeare T.A., Faber V., Feng D., Fowler D.R., Goldy J., Gregor B.W., Haradon Z., Haynor D.R., Hohmann J.G., Horvath S., Howard R.E., Jeromin A., Jochim J.M., Kinnunen M., Lau C., Lazarz E.T., Lee C., Lemon T.A., Li L., Li Y., Morris J.A., Overly C.C., Parker P.D., Parry S.E., Reding M., Royall J.J., Schulkin J., Sequeira P.A., Slaughterbeck C.R., Smith S.C., Sodt A.J., Sunkin S.M., Swanson B.E., Vawter M.P., Williams D., Wohnoutka P., Zielke H.R., Geschwind D.H., Hof P.R., Smith S.M., Koch C., Grant S.G., Jones A.R. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012, 489:391-399.
23. Heller-Stilb B., van Roeyen C., Rascher K., Hartwig H.G., Huth A., Seeliger M.W., Warskulat U., Häussinger D. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 2002, 16:231-233.
24. Hornfeldt C.S., Smullin D.H., Schamber C.D., Sun X., Larson A.A. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sci 1992, 50:1925-1934.
25. Hsu C.C., Lin R.L., Lee L.Y., Lin Y.S. Hydrogen sulfide induces hypersensitivity of rat capsaicin-sensitive lung vagal neurons: role of TRPA1 receptors. Am J Physiol Regul Integr Comp Physiol 2013, 307(7):R769-R779.
26. Hummel T., Knecht M., Wolf S., Kobal G. Recording of electro-olfactograms in man. Chem Senses 1996, 21:481.
27. Hummel T., Landis B.N., Hüttenbrink K.-B. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg 2011, 10. Doc04.
28. Hummel T., Mohammadian P., Marchl R., Kobal G., Lötsch J. Pain in the trigeminal system: irritation of the nasal mucosa using short- and long-lasting stimuli. Int J Psychophysiol 2003, 47:147-158.
29. Hummel T., Pietsch H., Kobal G. Kallmann's syndrome and chemosensory evoked potentials. Eur Arch Otorhinolaryngol 1991, 248:311-312.
30. Hussy N., Brès V., Rochette M., Duvoid A., Alonso G., Dayanithi G., Moos F.C. Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci 2001, 21:7110-7116.
31. Hussy N., Deleuze C., Bres V., Moos F.C. New role of taurine as an osmomediator between glial cells and neurons in the rat supraoptic nucleus. Adv Exp Med Biol 2000, 483:227-237.
32. Hussy N., Deleuze C., Desarménien M.G., Moos F.C. Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol 2000, 62:113-134.
33. Hussy N., Deleuze C., Pantaloni A., Desarménien M.G., Moos F. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J Physiol 1997, 502(Pt 3):609-621.
34. Huxtable R.J., Pierno S., De Luca A., Camerino C., Camerino D.C. Expanding the circle 1975-1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 2000, 483:1-25.
35. Jacobsen J.G., Smith L.H. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968, 48:424-511.
36. Jung M.K., Kim K.Y., Lee N.Y., Kang Y.S., Hwang Y.J., Kim Y., Sung J.J., McKee A., Kowall N., Lee J., Ryu H. Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS. Mol Neurobiol 2013, 47:699-710.
37. Kaneko M., Hammond D.L. Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther 1997, 282:928-938.
38. Kimura Y., Mikami Y., Osumi K., Tsugane M., Oka J., Kimura H. Polysulfides are possible H2S-derived signaling molecules in rat brain. FASEB J 2013, 27:2451-2457.
39. Knecht M., Hummel T., Wolf S., Kobal G. Assessment of the peripheral input signal to the olfactory system in man: the electro-olfactogram. Eur J Physiol 1995, R47.
40. Kobal G. Elektrophysiologische untersuchungen des menschlichen geruchsinnes 1981, Thieme-Verlag, Stuttgart.
41. Kobal G. Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 1985, 22:151-163.
42. Kobal G, Hummel T Human electro-olfactograms and brain responses to olfactory stimulation. The human sense of smell 1992, 135-151. Springer, Berlin. D.G. Laing (Ed.).
43. Kobal G., Hummel T. Olfactory and intranasal trigeminal event-related potentials in anosmic patients. Laryngoscope 1998, 108:1033-1035.
44. Lapid H., Shushan S., Plotkin A., Voet H., Roth Y., Hummel T., Schneidman E., Sobel N. Neural activity at the human olfactory epithelium reflects olfactory perception. Nat Neurosci 2011, 14:1455-1461.
45. Lim H.Y., Albuquerque B., Haussler A., Myrczek T., Ding A., Tegeder I. Progranulin contributes to endogenous mechanisms of pain defense after nerve injury in mice. J Cell Mol Med 2012, 16:708-721.
46. Lima L., Obregon F., Cubillos S., Fazzino F., Jaimes I. Taurine as a micronutrient in development and regeneration of the central nervous system. Nutr Neurosci 2001, 4:439-443.
47. Livermore A., Hummel T., Kobal G. Chemosensory event-related potentials in the investigation of interactions between the olfactory and the somatosensory (trigeminal) systems. Electroencephalogr Clin Neurophysiol 1992, 83:201-210.
48. Lötsch J., Doehring A., Mogil J.S., Arndt T., Geisslinger G., Ultsch A. Functional genomics of pain in analgesic drug development and therapy. Pharmacol Ther 2013, 139(1):60-70.
49. Lötsch J., Walter C., Felden L., Noth U., Deichmann R., Oertel B.G. The human operculo-insular cortex is pain-preferentially but not pain-exclusively activated by trigeminal and olfactory stimuli. PLoS One 2012, 7:e34798.
50. Lourenco R., Camilo M.E. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 2002, 17:262-270.
51. McNamara C.R., Mandel-Brehm J., Bautista D.M., Siemens J., Deranian K.L., Zhao M., Hayward N.J., Chong J.A., Julius D., Moran M.M., Fanger C.M. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 2007, 104:13525-13530.
52. Mizushima T., Obata K., Katsura H., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Tokunaga A., Mashimo T., Noguchi K. Noxious cold stimulation induces mitogen-activated protein kinase activation in transient receptor potential (TRP) channels TRPA1- and TRPM8-containing small sensory neurons. Neuroscience 2006, 140:1337-1348.
53. Patapoutian A., Tate S., Woolf C.J. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 2009, 8:55-68.
54. Pellicer F., Lopez-Avila A., Coffeen U., Manuel Ortega-Legaspi J., Angel R.D. Taurine in the anterior cingulate cortex diminishes neuropathic nociception: a possible interaction with the glycine(A) receptor. Eur J Pain 2007, 11:444-451.
55. Pow D.V., Sullivan R., Reye P., Hermanussen S. Localization of taurine transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary, and brain. Glia 2002, 37:153-168.
56. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 2000, 288:1769-1772.
57. Ramamoorthy S., Leibach F.H., Mahesh V.B., Han H., Yang-Feng T., Blakely R.D., Ganapathy V. Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem J 1994, 300(Pt 3):893-900.
58. Rana S.K., Sanders T.A. Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores. Br J Nutr 1986, 56:17-27.
59. Reymond I., Almarghini K., Tappaz M. Immunocytochemical localization of cysteine sulfinate decarboxylase in astrocytes in the cerebellum and hippocampus: a quantitative double immunofluorescence study with glial fibrillary acidic protein and S-100 protein. Neuroscience 1996, 75:619-633.
60. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., Low M.J. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci U S A 1996, 93:3995-4000.
61. Saransaari P., Oja S.S. Taurine and neural cell damage. Amino Acids 2000, 19:509-526.
62. Sergeeva O.A., Chepkova A.N., Doreulee N., Eriksson K.S., Poelchen W., Monnighoff I., Heller-Stilb B., Warskulat U., Haussinger D., Haas H.L. Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. J Physiol 2003, 550:911-919.
63. Sergeeva O.A., Fleischer W., Chepkova A.N., Warskulat U., Haussinger D., Siebler M., Haas H.L. GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition. J Physiol 2007, 585:539-548.
64. Serrano M.I., Serrano J.S., Fernandez A., Asadi I., Serrano-Martino M.C. GABA(B) receptors and opioid mechanisms involved in homotaurine-induced analgesia. General Pharmacol 1998, 30:411-415.
65. Silva M.A., Cunha G.M., Viana G.S., Rao V.S. Taurine modulates chemical nociception in mice. Braz J Med Biol Res 1993, 26:1319-1324.
66. Sinke A.P., Deen P.M. The physiological implication of novel proteins in systemic osmoregulation. FASEB J 2011, 25:3279-3289.
67. Smith H.S. Hydrogen sulfide's involvement in modulating nociception. Pain Physician 2009, 12:901-910.
68. Smullin D.H., Skilling S.R., Larson A.A. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 1990, 42:93-101.
69. South S.M., Smith M.T. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats. J Pharmacol Exp Ther 1998, 286:1326-1332.
70. Stapleton P.P., Charles R.P., Redmond H.P., Bouchier-Hayes D.J. Taurine and human nutrition. Clin Nutr 1997, 16:103-108.
71. Sturman J.A., Gargano A.D., Messing J.M., Imaki H., Aguirre G.D. Feline maternal taurine deficiency: effect on mother and offspring. Retinal degeneration associated with the feeding of dog foods to cats. J Nutr 1986, 116:655-667.
72. Sudbury J.R., Bourque C.W. Dynamic and permissive roles of TRPV1 and TRPV4 channels for thermosensation in mouse supraoptic magnocellular neurosecretory neurons. J Neurosci 2013, 33:17160-17165.
73. Sudbury J.R., Ciura S., Sharif-Naeini R., Bourque C.W. Osmotic and thermal control of magnocellular neurosecretory neurons - role of an N-terminal variant of trpv1. Eur J Neurosci 2010, 32:2022-2030.
74. Tarun A.S., Bryant B., Zhai W., Solomon C., Shusterman D. Gene expression for carbonic anhydrase isoenzymes in human nasal mucosa. Chem Senses 2003, 28:621-629.
75. Thürauf N., Friedel I., Hummel C., Kobal G. The mucosal potential elicited by noxious chemical stimuli: is it a peripherical nociceptive event. Neurosci Lett 1991, 128:297-300.
76. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain 1992, 51:5-17.
77. Tomi M., Tajima A., Tachikawa M., Hosoya K. Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells. Biochim Biophys Acta 2008, 1778:2138-2142.
78. Uchida S., Kwon H.M., Yamauchi A., Preston A.S., Marumo F., Handler J.S. Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl(-)-dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci U S A 1992, 89:8230-8234.
79. Vetter I., Touska F., Hess A., Hinsbey R., Sattler S., Lampert A., Sergejeva M., Sharov A., Collins L.S., Eberhardt M., Engel M., Cabot P.J., Wood J.N., Vlachova V., Reeh P.W., Lewis R.J., Zimmermann K. Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling. EMBO J 2012, 31:3795-3808.
80. Vitvitsky V., Garg S.K., Banerjee R. Taurine biosynthesis by neurons and astrocytes. J Biol Chem 2011, 286:32002-32010.
81. Walz W., Allen A.F. Evaluation of the osmoregulatory function of taurine in brain cells. Exp Brain Res 1987, 68:290-298.
82. 2. J Neurosci 2010, 30:12958-12963.
83. Warskulat U., Borsch E., Reinehr R., Heller-Stilb B., Monnighoff I., Buchczyk D., Donner M., Flogel U., Kappert G., Soboll S., Beer S., Pfeffer K., Marschall H.U., Gabrielsen M., Amiry-Moghaddam M., Ottersen O.P., Dienes H.P., Haussinger D. Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J 2006, 20:574-576.
84. Warskulat U., Borsch E., Reinehr R., Heller-Stilb B., Roth C., Witt M., Haussinger D. Taurine deficiency and apoptosis: findings from the taurine transporter knockout mouse. Arch Biochem Biophys 2007, 462:202-209.
85. Warskulat U., Flogel U., Jacoby C., Hartwig H.G., Thewissen M., Merx M.W., Molojavyi A., Heller-Stilb B., Schrader J., Haussinger D. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. Faseb J 2004, 18(3):577-579.
86. Warskulat U., Heller-Stilb B., Oermann E., Zilles K., Haas H., Lang F., Haussinger D. Phenotype of the taurine transporter knockout mouse. Methods Enzymol 2007, 428:439-458.
87. White A., Fishman J.B. The formation of taurine by the decarboxylation of cysteic acid. J Biol Chem 1936, 116:457-461.
88. Young E.E., Lariviere W.R., Belfer I. Genetic basis of pain variability: recent advances. J Med Genet 2012, 49:1-9.
89. Zeilhofer H.U., Wildner H., Yevenes G.E. Fast synaptic inhibition in spinal sensory processing and pain control. Physiol Rev 2012, 92:193-235.
90. Zhang X.F., Chen J., Faltynek C.R., Moreland R.B., Neelands T.R. Transient receptor potential A1 mediates an osmotically activated ion channel. Eur J Neurosci 2008, 27:605-611.
91. Zimmermann K., Lennerz J.K., Hein A., Link A.S., Kaczmarek J.S., Delling M., Uysal S., Pfeifer J.D., Riccio A., Clapham D.E. Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system. Proc Natl Acad Sci U S A 2011, 108:18114-18119.
92. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.